Detection of malignant neoplasms procoagulant activity

Cover Page


Cite item

Full Text

Abstract

Aim. To determine possibilities of malignant neoplasms procoagulant activity detection by idiopathic thrombosis ultrasound imaging.

Methods. 587 patients were examined. 347 patients with malignant neoplasms diagnosed in the outpatient clinic settings of the Tatarstan Regional Clinical Cancer Center (Kazan), were included in the main group. 240 patients, in which cancer pathology was excluded, were included in the control group. The groups were matched on age, sex and frequency of venous thromboembolic complications development risk factors not caused by malignant neoplasms. Both groups underwent clinical examination and ultrasound examination of the inferior vena cava, distal abdominal aorta, iliac arteries and veins, lower extremities arteries and veins.

Results. Thrombosis clinical manifestations were detected in 12 patients, including 9 patients of the main group and 3 patients of the control group. In most cases of venous thrombosis in the main group (34 people, 79%) there were no clinical signs of thrombosis and it was detected only by ultrasound examination, which allowed to detect venous thrombus in 43 patients of the main group (12.4%) and in 5 patients of the control group (2.1%; t=3.2, p <0.05).

Conclusion. The inferior vena cava system venous thrombosis frequency in patients with malignant neoplasms was significantly higher than that in patients without cancer, which indicates malignant neoplasms high procoagulant activity; ultrasonography has high sensitivity in the idiopathic thrombosis detection in cancer patients, and it should be performed regardless of the presence or absence of venous thromboembolic complications clinical manifestations.

About the authors

I A Kamalov

Tatarstan Regional Clinical Cancer Center; Kazan State Medical Academy

Author for correspondence.
Email: ki20@bk.ru

R S Kurtasanov

Kazan State Medical Academy; Volga Region Branch of Russian Cancer Research Center named after N.N. Blokhin

Email: ki20@bk.ru

References

  1. Асамов Р.Э., Туляков Р.П., Муминов Ш.М. и др. Бессимптомные флеботромбозы и наследственная тромбофилия у больных со скелетной травмой. Ангиол. и сосудист. хир. 2008; 14 (3): 73-75.
  2. Баркаган З.С. Патогенез и терапия нарушений гемостаза у онкологических больных. В кн.: Поддерживающая терапия у онкологических больных. Европейская школа по онкологии. Под ред. М. Личиницер. М.: Арго. 1996; 217-224.
  3. Гуляев Д.В. Эффективность и перспективы применения антикоагулянтов при лечении больных со злокачественными новообразованиями. Онкология. 2000; 2 (3): 218-224.
  4. Гуляев Д.В. Тромбоз у «нехирургических» больных со злокачественными новообразованиями: профилактика и лечение. Онкология. 2001; 3 (2-3): 113-118.
  5. Макаренко Т.П., Харитонова Л.Г., Богданов А.В. Ведение больных общехирургического профиля в послеоперационном периоде. М.: Медицина. 1989; 75-221.
  6. Тарабрин О.А., Мазуренко А.И. Нарушения системы гемостаза у онкологических больных. Онкогинекология. 2015; (3): 48-56.
  7. Шапошников С.А., Синьков С.В., Заболотских И.Б. Нарушения гемостаза при онкологическом процессе: современный взгляд на проблему. Вестн. РОНЦ им. Н.Н. Блохина РАМН. 2011; 22 (3): 12-20.
  8. Шилова А.Н., Баркаган З.С. Современные данные о частоте и патогенезе онкотромбозов. Тромбоз. Гемостаз. Реология. 2006; (1): 6-15.
  9. Carrier M., LeGal C., Wells P.S. et al. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Int Med. 2008; 149 (5): 323-333. http://dx.doi.org/10.7326/0003-4819-149-5-200809020-00007
  10. Carson J.L., Relley M.A., Duff A. et al. The clinical course of pulmonary embolism. N Engl J Med. 1992; 326: 1240-1245. http://dx.doi.org/10.1056/NEJM199205073261902
  11. Cornuz J., Pearson S.D., Creager M.A. et al. Importance of findings of the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med. 1996; 125: 785-793. http://dx.doi.org/10.7326/0003-4819-125-10-199611150-00001
  12. Dotsenko О., Kakkar A.K. Thrombosis and cancer. Ann Oncol. 2006; 17 (10): 81-84.
  13. Goldberg R.J., Seneff M., Gore J.M. et al. Occult malignant neoplasms in patients with deep venous thrombosis. Arch Intern Med. 1987; 147: 251-253. http://dx.doi.org/10.1001/archinte.1987.00370020071039
  14. Griffin M.R., Stanson A.S., Brown M.L. et al. Deep venous thrombosis and pulmonary embolism. Risk of subsequent malignant neoplasm. Arch Intern Med. 1987; 147: 1907-1911. http://dx.doi.org/10.1001/archinte.1987.00370110035004
  15. Imberti D., Ageno W., Dentali F. et al. Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation. J Thromb Haemost. 2006; 4 (5): 1037-1041. http://dx.doi.org/10.1111/j.1538-7836.2006.01940.x
  16. Nordstrom M., Lindbald B., Anderson H. et al. Deep vein thrombosis and occult malignancy: An epidemiological study. Br Med J. 1994; 308: 891-894. http://dx.doi.org/10.1136/bmj.308.6933.891
  17. Piccioli A., Prandoni Р. Idiopathic venous thromboembolism as afirst manifestation of cancer. Haemostasis. 2001; 31 (1): 37-39.
  18. Prandoni P., Lensing A.W.A., Buller H.R. et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 1992; 327: 1128-1133. http://dx.doi.org/10.1056/NEJM199210153271604
  19. Prandoni P., Falanga А., Piccioli А. Cancer and venous thromboembolism. Lancet Oncol. 2005; 6 (6): 401-410. http://dx.doi.org/10.1016/S1470-2045(05)70207-2
  20. Sheikh M.A., Topoulos А.Р., Deitcher S.R. Isolated internal jugular vein thrombosis and the subsequent diagnosis of cancer. Thromb Haemost. 2001. Suppl. Abst. OC 1018.
  21. Subramaniam R.M., Heath R., Chou T. et al. Deep venous thrombosis: Withholding anticoagulation therapy after negative complete lower limb US findings. Radiology. 2005; 237 (1): 348-352. http://dx.doi.org/10.1148/radiol.2371041294
  22. Trousseau A. Phlegmasia alba dolens. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. London: New Sydenham Society. 1872; 281-295.

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Kamalov I.A., Kurtasanov R.S.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies